Interestingly, a particular angiotensin converting enzyme (ACE) genetic polymorphism (D/D), although not a ACE2 polymorphism, associates with decreased ACE2 levels and has been suggested to be protective in patients with COVID-19 (61–63). Here, ACE2 is linked to COVID-19.